News

Article

GSK Increases Stake in Indian Subsidiary

GlaxoSmithKline has increased its stake in its Indian subsidiary, GlaxoSmithKline Consumer Healthcare Ltd, from 43.2% to 72.5%.

GlaxoSmithKline has increased its stake in its Indian subsidiary, GlaxoSmithKline Consumer Healthcare Ltd, from 43.2% to 72.5%. GSK hopes that the transaction will increase the company’s exposure to India, which it describes as a key emerging market. The tender offer for the shares was undertaken by GSk’s subsidiary in Singapore, GlaxoSmithKline Pte. Ltd.

The offer was first announced in November 2012 and commenced on 17 January 2013. According to a press statement, shareholders of GlaxoSmithKline Consumer Healthcare Ltd tendered shares representing 29.3% (12,319,749) of the total outstanding shares.

The offer of 3900 Indian Rupees ($73.22) values the transaction at approximately $90 million. The final payment for shares tendered and accepted will be completed on or before February 13 2013. After this point, GlaxoSmithKline Pte. Ltd, will acquire full beneficial ownership of the shares tendered in the offer.

In a statement, David Redfern, chief strategy office at GSK, said, “We are very pleased with the outcome of this transaction, which will further increase our exposure to a key emerging market. It is a significant vote of confidence in the long-term growth prospects of our Consumer Healthcare business in India.”

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content